216 related articles for article (PubMed ID: 34326635)
1. Hyaluronic Acid Coated Liposomes Co-Delivery of Natural Cyclic Peptide RA-XII and Mitochondrial Targeted Photosensitizer for Highly Selective Precise Combined Treatment of Colon Cancer.
Xu Y; Yao Y; Wang L; Chen H; Tan N
Int J Nanomedicine; 2021; 16():4929-4942. PubMed ID: 34326635
[TBL] [Abstract][Full Text] [Related]
2. RA-XII, a bicyclic hexapeptidic glucoside isolated from Rubia yunnanensis Diels, exerts antitumor activity by inhibiting protective autophagy and activating Akt-mTOR pathway in colorectal cancer cells.
Wang J; Wang J; Li L; Feng L; Wang YR; Wang Z; Tan NH
J Ethnopharmacol; 2021 Feb; 266():113438. PubMed ID: 33017635
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial targeted hierarchical drug delivery system based on HA-modified liposomes for cancer therapy.
Chen H; Fang Z; Song M; Liu K
Eur J Med Chem; 2022 Nov; 241():114648. PubMed ID: 35963128
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity evaluation of meso-tetra (pyrrolidine substituted) pentylporphin-mediated photodynamic therapy in vitro and in vivo.
Zhang LJ; Zhang XH; Liao PY; Sun JJ; Wang L; Yan YJ; Chen ZL
J Photochem Photobiol B; 2016 Oct; 163():224-31. PubMed ID: 27591565
[TBL] [Abstract][Full Text] [Related]
5. Programmed delivery of cyclopeptide RA-V and antisense oligonucleotides for combination therapy on hypoxic tumors and for therapeutic self-monitoring.
Yao Y; Feng L; Wang Z; Chen H; Tan N
Biomater Sci; 2019 Dec; 8(1):256-265. PubMed ID: 31687671
[TBL] [Abstract][Full Text] [Related]
6. ROS-responsive liposomes with NIR light-triggered doxorubicin release for combinatorial therapy of breast cancer.
Yi H; Lu W; Liu F; Zhang G; Xie F; Liu W; Wang L; Zhou W; Cheng Z
J Nanobiotechnology; 2021 May; 19(1):134. PubMed ID: 33975609
[TBL] [Abstract][Full Text] [Related]
7. Overcoming drug-resistant lung cancer by paclitaxel-loaded hyaluronic acid-coated liposomes targeted to mitochondria.
Tian Y; Zhang H; Qin Y; Li D; Liu Y; Wang H; Gan L
Drug Dev Ind Pharm; 2018 Dec; 44(12):2071-2082. PubMed ID: 30112929
[TBL] [Abstract][Full Text] [Related]
8. A stabilized retro-inverso peptide ligand of transferrin receptor for enhanced liposome-based hepatocellular carcinoma-targeted drug delivery.
Tang J; Wang Q; Yu Q; Qiu Y; Mei L; Wan D; Wang X; Li M; He Q
Acta Biomater; 2019 Jan; 83():379-389. PubMed ID: 30395963
[TBL] [Abstract][Full Text] [Related]
9. Mitochondria-targeting near-infrared light-triggered thermosensitive liposomes for localized photothermal and photodynamic ablation of tumors combined with chemotherapy.
Yue C; Yang Y; Song J; Alfranca G; Zhang C; Zhang Q; Yin T; Pan F; de la Fuente JM; Cui D
Nanoscale; 2017 Aug; 9(31):11103-11118. PubMed ID: 28741634
[TBL] [Abstract][Full Text] [Related]
10. A pH-Activatable nanoparticle for dual-stage precisely mitochondria-targeted photodynamic anticancer therapy.
Qi T; Chen B; Wang Z; Du H; Liu D; Yin Q; Liu B; Zhang Q; Wang Y
Biomaterials; 2019 Aug; 213():119219. PubMed ID: 31132647
[TBL] [Abstract][Full Text] [Related]
11. Natural Cyclopeptide RA-XII, a New Autophagy Inhibitor, Suppresses Protective Autophagy for Enhancing Apoptosis through AMPK/mTOR/P70S6K Pathways in HepG2 Cells.
Song L; Wang Z; Wang Y; Guo D; Yang J; Chen L; Tan N
Molecules; 2017 Nov; 22(11):. PubMed ID: 29137114
[TBL] [Abstract][Full Text] [Related]
12. Antitumor Effect of Hyperoside Loaded in Charge Reversed and Mitochondria-Targeted Liposomes.
Feng Y; Qin G; Chang S; Jing Z; Zhang Y; Wang Y
Int J Nanomedicine; 2021; 16():3073-3089. PubMed ID: 33953556
[TBL] [Abstract][Full Text] [Related]
13. Eph A10-modified pH-sensitive liposomes loaded with novel triphenylphosphine-docetaxel conjugate possess hierarchical targetability and sufficient antitumor effect both in vitro and in vivo.
Zhang J; Yang C; Pan S; Shi M; Li J; Hu H; Qiao M; Chen D; Zhao X
Drug Deliv; 2018 Nov; 25(1):723-737. PubMed ID: 29513049
[TBL] [Abstract][Full Text] [Related]
14. Deepened cellular/subcellular interface penetration and enhanced antitumor efficacy of cyclic peptidic ligand-decorated accelerating active targeted nanomedicines.
Shi NQ; Li Y; Zhang Y; Li ZQ; Qi XR
Int J Nanomedicine; 2018; 13():5537-5559. PubMed ID: 30271146
[TBL] [Abstract][Full Text] [Related]
15. Multiple targeted doxorubicin-lonidamine liposomes modified with p-hydroxybenzoic acid and triphenylphosphonium to synergistically treat glioma.
Lu J; Li R; Mu B; Peng Y; Zhao Y; Shi Y; Guo L; Hai L; Wu Y
Eur J Med Chem; 2022 Feb; 230():114093. PubMed ID: 35007860
[TBL] [Abstract][Full Text] [Related]
16. Reversal of multidrug resistance by co-delivery of paclitaxel and lonidamine using a TPGS and hyaluronic acid dual-functionalized liposome for cancer treatment.
Assanhou AG; Li W; Zhang L; Xue L; Kong L; Sun H; Mo R; Zhang C
Biomaterials; 2015 Dec; 73():284-95. PubMed ID: 26426537
[TBL] [Abstract][Full Text] [Related]
17. "Biotin-targeted mixed liposomes: A smart strategy for selective release of a photosensitizer agent in cancer cells".
de Freitas CF; Montanha MC; Pellosi DS; Kimura E; Caetano W; Hioka N
Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109923. PubMed ID: 31499973
[TBL] [Abstract][Full Text] [Related]
18. Overcoming drug-resistant lung cancer by paclitaxel loaded dual-functional liposomes with mitochondria targeting and pH-response.
Jiang L; Li L; He X; Yi Q; He B; Cao J; Pan W; Gu Z
Biomaterials; 2015 Jun; 52():126-39. PubMed ID: 25818419
[TBL] [Abstract][Full Text] [Related]
19. Core-matched nanoassemblies for targeted co-delivery of chemotherapy and photosensitizer to treat drug-resistant cancer.
Jiang D; Xu M; Pei Y; Huang Y; Chen Y; Ma F; Lu H; Chen J
Acta Biomater; 2019 Apr; 88():406-421. PubMed ID: 30763634
[TBL] [Abstract][Full Text] [Related]
20. Tumor mitochondria-targeted photodynamic therapy with a translocator protein (TSPO)-specific photosensitizer.
Zhang S; Yang L; Ling X; Shao P; Wang X; Edwards WB; Bai M
Acta Biomater; 2015 Dec; 28():160-170. PubMed ID: 26432436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
